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Objectives This study sought to characterize temporal trends in hospitalizations with heart failure as a primary or secondary diagnosis.
Background Heart failure patients are frequently admitted for both heart failure and other causes.
Methods Using the Nationwide Inpatient Sample (NIS), we evaluated trends in heart failure hospitalizations between 2001
and 2009. Hospitalizations were categorized as either primary or secondary heart failure hospitalizations based
on the location of heart failure in the discharge diagnosis. National estimates were calculated using the sam-
pling weights of the NIS. Age- and sex-standardized hospitalization rates were determined by dividing the num-
ber of hospitalizations by the U.S. population in a given year and using direct standardization.
Results The number of primary heart failure hospitalizations in the United States decreased from 1,137,944 in 2001 to
1,086,685 in 2009, whereas secondary heart failure hospitalizations increased from 2,753,793 to 3,158,179
over the same period. Age- and sex-adjusted rates of primary heart failure hospitalizations decreased steadily
from 2001 to 2009, from 566 to 468 per 100,000 people. Rates of secondary heart failure hospitalizations ini-
tially increased from 1,370 to 1,476 per 100,000 people from 2001 to 2006, then decreased to 1,359 per
100,000 people in 2009. Common primary diagnoses for secondary heart failure hospitalizations included pul-
monary disease, renal failure, and infections.
Conclusions Although primary heart failure hospitalizations declined, rates of hospitalizations with a secondary diagnosis of
heart failure were stable in the past decade. Strategies to reduce the high burden of hospitalizations of heart
failure patients should include consideration of both cardiac disease and noncardiac conditions. (J Am Coll
Cardiol 2013;61:1259–67) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.12.038Heart failure is one of the most common reasons for
hospital admission in the United States. Given this substan-
tial morbidity, efforts have been made to reduce the number
of hospitalizations related to this disease. A number of
therapies have been developed over the last 2 decades that
have been shown to reduce heart failure hospitalizations
(1–8), and quality improvement initiatives have been devel-
oped to ensure delivery of these evidence-based therapies
(9,10). To encourage such initiatives, the Center for Medicare
and Medicaid Services began reporting on the quality of care and
rate of heart failure rehospitalization for hospitals (11).
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2012, accepted December 16, 2012.The development of evidence-based treatments and initia-
tives to improve care delivery might be improving outcomes for
patients. For example, although studies demonstrated that the
rates of heart failure hospitalizations increased in the 1980s and
1990s (12,13), recent data from Medicare indicated that
hospitalizations with a primary diagnosis of heart failure in the
elderly declined over the last decade (14). These findings were
attributed to both improvements in treatment and reduction in
See page 1268
prevalent heart failure (14). Nonetheless, the majority of
hospitalizations of heart failure patients are for reasons other
than acute heart failure (15,16). Quality improvement initia-
tives typically target only hospitalizations with a primary
diagnosis of heart failure; therefore, these initiatives may not
affect comorbid conditions that are associated with, but not
directly caused by, heart failure. We sought to evaluate recent
trends in primary and secondary heart failure hospitalizations
in the United States using an all-payer, representative survey of
inpatient admissions.
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The Nationwide Inpatient Sample
(NIS) is part of the Healthcare
Cost and Utilization Project
(HCUP), sponsored by the
Agency for Healthcare Research
and Quality (AHRQ) (17). The
NIS represents the largest all-
payer hospitalization database in
the United States and samples ap-
proximately 8 million hospitaliza-
tions per year to represent national estimates.
We included all heart failure hospitalizations between
2001 and 2009 for patients 18 years of age. The primary
nit of analysis was a patient hospitalization. Individual
atients cannot be tracked longitudinally in the NIS; thus, a
atient might have contributed to more than 1 observation
n a given year. Heart failure was based on the following
nternational Classification of Diseases-Ninth Revision,
linical Modification (ICD-9-CM) discharge diagnosis
odes in any position: 402.01, 402.11, 402.91, 404.01,
04.03, 404.11, 404.13, 404.91, 404.93, and 428 (18). If 1
f these codes was listed in the first position, the admission
as considered to be a primary heart failure hospitalization;
therwise, the admission was considered to be a secondary
eart failure hospitalization. The NIS abstracts up to 15
ischarge diagnosis codes, although actual hospitalizations
ay list more diagnoses (17).
All patient and hospital characteristics were obtained
rom the NIS. Patient characteristics included demographic
nd outcome characteristics and comorbidities. Age was
resented as a continuous variable and categorized as 18 to
9, 50 to 64, 65 to 74, 75 to 84, and 85 years of age. Race
as categorized as white, black, or other. The primary payer
or the hospitalization was categorized as Medicare, Med-
caid, private insurance, self-pay, or other. Number of
hronic conditions was defined by summing the Elixhauser
omorbidity index (19), and individual comorbidities were
ssessed using the HCUP Clinical Classification Software
CCS) definitions (20). Hospital characteristics included
egion of the country and rural versus urban density. Region
f the country was categorized as Northeast, Midwest,
outh, or West. Rural region was based on Metropolitan
tatistical Area codes before 2004 and Core Based Statis-
ical Area codes beginning in 2004 (17).
Hospitalization type was based on principal discharge
iagnosis. We categorized hospitalizations as heart failure
using the previously described codes), cardiovascular (ICD-
-CM codes between 390 and 459, with the exception of
hose for heart failure), and noncardiovascular (all other
odes). Hospitalizations were also described based on both
ndividual and multilevel CCS categories. Finally, we iden-
ified the top 10 CCS categories that were listed as the
Abbreviations
and Acronyms
CCS  Clinical
Classification Software
COPD  chronic obstructive
pulmonary disease
HCUP  Healthcare Cost
and Utilization Project
NIS  Nationwide Inpatient
Samplerimary discharge diagnoses.Outcome-related measures were presented separately for
both primary and secondary heart failure diagnoses and
included in-hospital mortality, length of stay, and discharge
disposition. Discharge disposition was categorized as rou-
tine, intermediate care transfers, and home health care.
Statistical analysis. All statistical analyses were performed
using the sampling weights and stratified sample design of
the NIS to obtain nationally representative estimates.
Descriptive statistics for hospitalizations were presented
as mean  SD for continuous variables and frequencies for
categorical variables. We used chi-square and one-way
analysis of variance to evaluate differences in categorical and
continuous variables across years. Chi-square and Student’s
t-tests were used to test differences in outcome characteris-
tics between hospitalizations that did and did not have heart
failure listed as the primary discharge diagnosis.
Annual rates of primary and secondary heart failure
hospitalizations were calculated by dividing the number of
hospitalizations by the U.S. population 18 years of age in
a given year. Population estimates for this study were
obtained from the U.S. Census Bureau. Age- and sex-
adjusted rates of hospitalization were determined using the
direct standardization method, adjusted to the 2009 popu-
lation. Changes in hospitalization rates between 2001 and
2009 were determined with Poisson regression, in which the
independent variable was the calendar year.
We performed subgroup analyses of hospitalization rates
for age and sex categories; we did not calculate rates by race
categories due to the large number of missing values
reported for this variable in the NIS (24.6%). Rates for
subgroups were determined by taking the number of hos-
pitalizations and dividing by the adult U.S. population for
the given category. We also calculated the age-adjusted rates
of hospitalization for sex using the population distribution
of age in 2009 irrespective of sex. We tested the significance
in trends with Poisson regression of number of hospitaliza-
tions per year, offset by the target population in the given
year.
Statistical analyses were performed using Stata 11 (Stata-
Corp., College Station, Texas).
Results
From 2001 to 2009, there were an estimated 37,563,876
hospitalizations with a primary or secondary diagnosis of
heart failure in the United States. Hospitalizations increased
from 3,891,737 in 2001 to 4,244,865 in 2009, although the
number of hospitalizations peaked in 2006 (Table 1).
The mean age of patients hospitalized with a diagnosis of
heart failure decreased over this period from 74.2 to 73.1
years; this decrease was primarily attributable to an increase
in the proportion of hospitalizations among patients 18 to
64 years of age, coupled with a decrease among patients 65
to 84 years of age (Table 1). The majority of hospitalized
patients were women and white, although the proportion of
each decreased over this period (55.9% to 52.7% and 77.4%
Characteristics of Hospitalizations With a Primary or Secondary Diagnosis ofHe t FailureTable 1 Characteris ics of Hospitaliz tions With a Primary or Secondary Diagnosis ofHeart Failure
Characteristics 2001 2002 2003 2004 2005 2006 2007 2008 2009
Heart failure hospitalizations 3,891,737 3,979,482 4,146,308 4,230,905 4,302,805 4,388,414 4,209,367 4,169,995 4,244,865
Age (yrs) 74.2 0.1 74.0 0.1 73.7 0.2 73.6 0.2 73.9 0.2 73.4 0.2 73.3 0.2 73.6 0.2 73.1 0.2
18–49 5.3 5.5 5.9 6.1 5.9 6.4 6.4 6.0 6.4
50–64 15.5 16.2 17.0 17.4 17.1 18.1 18.6 18.3 19.2
65–74 22.6 22.3 22.1 21.8 21.2 21.2 21.3 21.2 21.6
75–84 34.0 33.7 33.1 32.8 32.6 31.6 30.8 30.6 29.6
85 22.6 22.3 22.0 21.9 23.2 22.7 22.9 23.9 23.2
Female 55.9 55.7 55.5 54.8 54.5 53.9 53.7 53.4 52.7
Race
White 77.4 75.2 73.1 73.8 77.2 73.2 72.3 74.0 72.5
Black 13.1 14.6 14.9 15.6 12.1 15.1 16.1 14.7 15.5
Other 9.5 10.2 12.0 10.6 10.7 11.7 11.6 11.4 12.0
Rural region 20.0 18.8 19.0 16.8 16.6 16.0 15.9 15.9 15.1
Region
Northeast 20.3 20.9 21.0 19.4 19.6 19.9 19.5 19.0 19.8
Midwest 25.0 25.2 25.5 26.1 24.5 25.0 26.0 24.8 25.4
South 39.9 38.5 38.4 39.9 40.2 40.1 39.0 40.2 39.1
West 14.8 15.4 15.1 14.7 15.6 15.1 15.5 16.1 15.7
Primary payer
Medicare 78.2 78.8 79.2 78.1 79.5 78.4 77.0 76.4 76.3
Medicaid 5.7 5.7 6.2 6.3 6.1 6.5 6.4 6.4 7.1
Private insurance 13.1 12.5 11.6 12.0 11.0 11.4 12.4 13.1 12.4
Other 3.1 3.1 3.0 3.6 3.5 3.8 4.1 4.1 4.3
No.of comorbidities 5.58 0.01 5.69 0.02 5.76 0.01 5.83 0.02 5.88 0.02 5.92 0.02 5.88 0.02 5.85 0.02 5.91 0.02
Primary heart failure diagnosis 29.2 28.4 28.4 27.4 26.3 25.9 25.4 25.6 25.6
Comorbidities
Diabetes 35.5 36.5 36.8 36.9 36.7 37.7 39.7 40.1 41.1
Fluid and electrolyte disorders 23.6 24.9 25.5 26.9 28.5 29.0 30.1 29.4 30.4
Heart valve disorders 16.0 16.4 16.8 16.7 17.4 18.0 17.9 16.5 17.4
Acute myocardial infarction 9.2 9.2 8.9 8.4 8.2 7.9 7.9 8.0 7.9
Coronary atherosclerosis 46.8 46.9 46.7 46.6 46.1 46.9 47.8 49.7 49.8
Cardiac dysrhythmias 36.5 37.6 37.8 38.9 39.7 40.3 40.9 40.8 41.7
Peripheral atherosclerosis 6.8 7.2 7.0 7.2 7.1 7.5 8.1 8.6 8.7
Pneumonia 14.3 15.0 15.5 15.6 16.9 16.3 16.9 17.2 17.0
COPD 29.5 30.5 30.3 30.6 31.6 31.6 31.9 30.1 30.3
Renal failure 10.6 11.8 13.0 14.3 18.7 27.4 36.0 36.9 40.1
Delirium and dementia 8.4 8.9 8.9 9.1 9.2 9.5 10.0 11.2 10.9
Anemia 21.5 22.4 22.9 23.8 23.9 24.5 26.7 28.8 30.1
Mental illness 25.5 27.9 28.5 29.6 30.7 32.7 34.7 37.9 38.3
Hypertension 53.2 56.2 57.9 59.9 60.9 64.1 65.2 68.2 69.9
Cerebrovascular disease 8.2 8.1 7.7 7.6 7.4 7.5 7.7 8.4 8.3
Liver disease 3.2 3.5 3.6 3.8 4.0 4.2 4.1 4.6 5.1
Values are n, mean  SD, or %. The p values for trends across years were p  0.0001, with the exception of race (p  0.01), rural region (p  0.05) and region (p  0.9).
COPD  chronic obstructive pulmonary disease.
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Heart Failure–Associated Hospitalizations March 26, 2013:1259–67to 72.5%, respectively). Medicare was the most common
payer for hospitalizations.
The mean number of Elixhauser comorbidities increased
from 5.58 in 2001 to 5.91 in 2009 (Table 1). Cardiovascular
comorbidities, including coronary atherosclerosis, cardiac
arrhythmias, and hypertension, were common and increased
over this period. Additionally, the prevalence of a number of
related noncardiovascular comorbid conditions dramatically
increased between 2001 and 2009; for instance, the prevalence
of diabetes rose from 35.5% to 41.1%, renal disease from 10.6%
to 40.1%, and mental illness from 25.5% to 38.3%.
Of the total number of heart failure hospitalizations
between 2001 and 2009, 26.9% carried a primary diagnosis
of heart failure, whereas the remaining 73.1% were second-
ary heart failure hospitalizations. The total number of
primary heart failure hospitalizations declined from an
estimated 1,137,944 hospitalizations in 2001 to 1,086,685
hospitalizations in 2009, representing an annual decrease of
1.0% (95% confidence interval [CI]: 0.9% to 1.0%) per year.
Conversely, secondary heart failure hospitalizations in-
creased from 2,753,793 to 3,158,179 over this period, with
an annual growth rate of 1.6% (95% CI: 1.6% to 1.6%). The
number of secondary heart failure hospitalizations peaked in
2006 at 3,252,693.
Age- and sex-standardized rates of primary heart failure
hospitalizations decreased during the study period, from
566 per 100,000 people in 2001 to 468 per 100,000 people
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Figure 1 Rates of Heart Failure–Related Hospitalization
Annual age- and sex-adjusted rates of hospitalizations in the United States with ain 2009 (Fig. 1). The annual rate of decline of primary heart
failure hospitalizations was 2.8% (95% CI: 1.7% to 3.8%).
Age- and sex-standardized rates of secondary heart failure
hospitalizations increased annually between 2001 and 2006
and then decreased the following 2 years to return to levels
that did not differ from those at the beginning of the decade.
Overall, there was no significant change in the age- and
sex-standardized rates of secondary heart failure hospital-
izations over this period (annual rate of change0.2%; 95%
CI: 0.9% to 0.4%).
Rates of primary heart failure hospitalizations among
patients ages 18 to 49 years increased overall between 2001
and 2009, although the rates peaked in 2004 to 2006 (Table 2).
mong all other age categories, primary heart failure
ospitalization rates declined. Secondary heart failure hos-
italizations increased significantly over the study period for
ubgroups of ages 18 to 49 and 50 to 64 years; however,
mong older patients, rates increased initially, but subse-
uently declined to rates below that of 2001. Both sexes
howed a similar pattern in trends as the overall cohort
Table 2). Although women had higher rates of hospitaliza-
ions compared with men, this difference was due to the older
ge distribution of women compared with men. With stan-
ardization to the 2009 population distribution for age among
ll sexes, men had higher rates of both primary (586 vs. 465 per
00,000 people) and secondary (1,526 vs. 1,324 per 100,000
eople) heart failure hospitalizations during this period.
005 2006 2007 2008 2009
sis of heart failure (HF) in the primary versus secondary position are shown.2
diagno
ies.
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diagnosis of heart failure decreased from 29.2% in 2001 to
25.6% in 2009. The rates of hospitalizations due to other
cardiovascular causes also decreased, whereas hospitaliza-
tions for noncardiovascular causes increased from 48.5% to
54.1% from 2001 to 2009. Over 16% of all hospitalizations
carried a primary diagnosis related to pulmonary disease; 6%
were related to digestive diseases, and nearly 6% were
related to injuries and poisoning (Table 3). Significant
increases in the percentage of hospitalizations for both renal
and infectious diseases were observed (Table 3). Among all
heart failure–related hospitalizations, pneumonia was the
second most common primary diagnosis (after heart failure),
although its prevalence significantly decreased during this
period (Fig. 2). Comparable declines in percentages of
hospitalizations were observed for acute myocardial infarc-
tion and coronary atherosclerosis, whereas other common
pulmonary diagnoses, such as chronic obstructive pulmo-
nary disease (COPD) and respiratory failure increased.
Hospitalizations for both sepsis and acute renal failure were
increasingly common over this period (Fig. 2).
In-hospital mortality rates significantly decreased over
the decade for both primary and secondary heart failure
hospitalizations (Table 4), with mortality rates nearly dou-
bling for secondary compared to primary heart failure
hospitalizations. Length of stay also decreased over this
period for both primary and secondary heart failure hospi-
talizations. Rates of both home health care and transfer to
intermediate-care facilities increased over the decade, and
both were more common among patients with a secondary
heart failure diagnosis (Table 4).
Discussion
In this nationally representative sample of hospitalizations
in the United States, the total number heart failure–related
hospitalizations increased from 3,891,737 in 2001 to
4,244,865 in 2009. During this period, primary heart failure
hospitalizations steadily decreased, whereas the total num-
Trends in Primary and Secondary Heart Failure Hby Age and Sex C tegoryTable 2 Trends in P imary and Secondary Hby Age and Sex Category
Characteristics
Primary
2001 to
2003
2004 to
2006
Age (yrs)
18–49 59 65
50–64 456 431
65–74 1,415 1,293
75–84 2,899 2,681
85 5,235 5,002
Sex
Female 565 520
Male 503 509
Estimates per 100,000 population; p trends  0.0001 for all categorber of secondary heart failure hospitalizations increased bynearly 400,000. As a result, the percentage of hospitalizations
attributable to causes other than heart failure increased and
accounted for 75% of the total number of heart failure–related
hospitalizations in the United States by 2009.
talizationsilure Hospitalizations
Secondary
7 to
09
2001 to
2003
2004 to
2006
2007 to
2009
61 108 131 134
84 983 1,071 1,045
95 3,462 3,641 3,376
73 7,601 7,906 7,303
21 14,784 14,991 13,499
62 1,448 1,532 1,438
72 1,205 1,312 1,285
Primary Diagnosis Category for HospitalizationsW th a Primary or Secondary Diagnosis ofHeart Failure
Table 3
Primary Diagnosis Category for Hospitalizations
With a Primary or Secondary Diagnosis of
Heart Failure
Characteristics
2001 to
2003
2004 to
2006
2007 to
2009
Cardiovascular diseases 49.9 46.3 45.3
Coronary atherosclerosis 4.2 3.6 3.1
Acute myocardial infarction 5.9 5.0 4.5
Cardiac dysrhythmias 3.7 3.7 4.4
Heart valve disorders 0.8 0.7 0.8
Cerebrovascular disease 2.5 2.4 2.3
Hypertension 3.3 2.7 2.8
Peripheral atherosclerosis 0.6 0.6 0.6
Respiratory diseases 16.0 16.5 16.6
COPD 3.5 3.3 3.9
Pneumonia 7.3 6.8 5.5
Diabetes 1.6 1.6 1.5
Fluid and electrolyte disorders 1.9 1.6 1.4
Genitourinary diseases 3.4 4.3 4.9
Renal Failure 1.5 2.3 2.8
Urinary tract infections 1.3 1.5 1.6
Diseases of the blood 1.0 1.1 1.1
Anemia 0.8 0.9 1.0
Diseases of the digestive system 6.2 6.4 6.1
Liver disease 0.4 0.4 0.3
Mental illness 1.2 1.2 1.2
Delirium and dementia 0.4 0.4 0.3
Infectious diseases 3.2 4.5 5.5
Skin infections 1.1 1.2 1.3
Neoplasms 2.3 2.3 2.0
Injury and poisoning 5.4 5.9 6.1
Fractures 2.0 2.1 2.1
Diseases of the musculoskeletal system 1.7 1.8 1.9
Symptoms, signs, and conditions 1.4 1.4 1.3
All others 4.9 5.2 5.3ospieart F
200
20
3
1,0
2,3
4,5
4
4COPD  chronic obstructive pulmonary disease.
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Heart Failure–Associated Hospitalizations March 26, 2013:1259–67Previous studies suggested that both primary and second-
ary heart failure hospitalizations increased significantly be-
tween 1973 and 2004 (12,13,21,22). Conversely, in a recent
study of Medicare beneficiaries, Chen et al. (14) found a
decrease in primary heart failure hospitalizations between
1998 and 2008. This study was the first to suggest that
primary heart failure hospitalization rates were decreasing in
the United States (23), a finding which our population
0% 1% 2%
Fluid and electrolyte disorders
Hypertension w/complicaons
Acute renal failure
Coronary atherosclerosis
Respiratory failure
Sepcemia
COPD
Cardiac dysrhythmias
Acute myocardial infarcon
Pneumonia
Figure 2 Trends in Prevalence of the 10 Most Common Primar
for Heart Failure–Related Hospitalizations, Other Than
Bars represent the percent of all heart failure–related hospitalizations that were re
Values of p 0.001 for each diagnosis across all years. COPD  chronic obstruct
Outcomes of Heart Failure Hospitalization, by Primary Versus SecoTable 4 Outcomes of Heart Failure Hospitalization, by Primary
2001 to 2003
Primary Secondary p Value
Sample size 3,446,627 8,560,084 3
Mortality 4.3 8.1 0.001
Length of stay 5.56 0.04 7.48 0.05 0.001 5
Discharge disposition 0.001
Routine 61.3 46.4
Hospital transfers 3.6 4.1
SNF and intermediate care
transfers
16.7 28.0
Home health care 13.3 12.9Value are n, %, or mean  SD.
SNF  skilled nursing facility.sample confirmed. However, our study demonstrated that
the number of secondary heart failure hospitalizations in-
creased during this period. This suggested that the improve-
ments observed during the last decade in primary heart
failure hospitalization rates were not realized for all-cause
hospitalization.
Our observed increase in secondary heart failure hospi-
talizations can be partly explained by the high number of
% 4% 5% 6% 7% 8%
2001-3
2004-6
2007-9
gnoses
rt Failure Itself
to a given diagnosis for a 3-year period.
lmonary disease.
Diagnosis of Heart Failures Secondary Diagnosis of Heart Failure
2004 to 2006 2007 to 2009
ry Secondary p Value Primary Secondary p Value
655 9,496,468 3,217,925 9,406,341
7.3 0.001 3.2 6.2 0.001
0.03 7.35 (0.04) 0.001 5.27 0.04 6.82 0.05 0.001
0.001 0.001
42.3 54.9 42.7
3.8 3.1 3.6
29.9 19.2 29.7
16.0 18.4 17.13
y Dia
Hea
lated
ive pundaryVersu
Prima
,425,
3.7
.37
56.8
3.5
18.3
16.6
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March 26, 2013:1259–67 Heart Failure–Associated Hospitalizationsrehospitalizations among patients with heart failure. Rehos-
pitalizations have not declined significantly in recent years,
(24,25) and most frequently are caused by conditions other
than heart failure; therefore, this category of hospitalizations
contributes primarily to secondary heart failure hospitaliza-
tions (23). As a result, interventions to reduce rehospital-
izations and secondary heart failure hospitalizations should
include consideration for treatment of comorbid conditions.
We did observe a trend of improvement in secondary heart
failure hospitalizations after 2006, suggesting that recent
interventions to reduce all-cause rehospitalizations may be
finding some success. Such interventions include clinical
interventions, such as the increase in home health services
observed in our study, and policy interventions, such as
public reporting of heart failure rehospitalizations by Medi-
care, which began during this period (26).
Clinical and policy interventions might have also contrib-
uted to the observed decrease in in-hospital mortality
observed in our study. This trend was consistent with earlier
studies of primary heart failure hospitalization in the Medi-
care population. However, those studies demonstrated little
to no improvement in post-discharge mortality and rehos-
pitalizations (24,27). The effect of recent interventions on
post-discharge outcomes deserves further attention.
Trends by age and sex. Our study demonstrated that the
reductions in primary heart failure hospitalizations among
the Medicare population were not observed in all age
groups. We found no change in the rate of primary heart
failure hospitalizations among patients 50 years of age
between 2001 and 2009. Furthermore, these younger adults
had the highest growth in secondary heart failure hospital-
izations during this time period. These findings suggested
that initiatives to reduce hospitalizations and rehospitaliza-
tions among heart failure patients should increase efforts to
target younger patients.
At the beginning of the study, women had higher rates of
primary heart failure hospitalizations than men. These sex
differences were consistent with previous studies (22). How-
ever, by the end of the study period, men had a higher rate
of primary heart failure hospitalizations. These results were
consistent with previous studies that suggested that the
prevalence of heart failure in men is increasing in compar-
ison to women (28).
Relationship with comorbid conditions. Both cardiovas-
cular and noncardiovascular comorbid conditions were com-
mon in patients hospitalized with heart failure and increased
over the study period. Although the high rates of diseases
such as diabetes, kidney disease, infections, and COPD
were not surprising because some of these conditions are
risk factors for heart failure (29,30), the presence of an
increased number of comorbidities were associated with
worse outcomes in heart failure (31–33). Furthermore, the
presence of multiple chronic conditions could make patient
management difficult due to issues such as greater medica-
tion burden, reduced adherence, treatment for 1 condition
worsening the other, and physician uncertainty (34,35). hNew models of clinical decision making and care delivery
are needed to address the needs of the increasing number of
patients with heart failure and comorbid conditions (35,36).
Comorbidities such as COPD and renal failure might
present with symptoms that are similar to heart failure,
which lent uncertainty to the primary diagnosis of hospital-
ization. Given this dilemma, our findings that primary heart
failure hospitalizations decreased, whereas secondary heart
failure hospitalizations increased might be related to
changes in coding practices. Medicare began tracking qual-
ity measures for primary heart failure hospitalizations in the
late 1990s, and this information became publicly available in
2004 (37,38). As a result of such initiatives, hospital coders
had incentive to become more prudent in assigning a
primary heart failure diagnosis to hospitalizations with
multiple acute medical issues, so such hospitalizations
would not be subject to public review. A similar “downcod-
ing” of pneumonia hospitalizations was suggested in a
recent study using the NIS dataset (39,40). In this context,
our finding of a decrease in primary heart failure hospital-
izations might be partly attributable to this shift in coding
practices.
Study limitations. First, diagnostic codes are subject to
misclassification, and we were unable to determine specifi-
cally whether a secondary diagnosis represented an active
condition versus a remote history of heart failure. We
addressed this issue by using an algorithm for ICD-9 coding
that was similar to well-validated algorithms (41–44) and
comparable to those used in previous studies (13). Second,
although the NIS collects data on 8 million hospitalizations
annually, or approximately 20% of all hospitalizations in the
United States, the dataset is a sample and may not fully
reflect all hospitalizations. Third, observations in NIS are at
the level of the hospitalization rather than at the patient
level, so we were unable to determine trends in the number
of patients hospitalized for heart failure. Nonetheless, the
total number of heart failure–related hospitalizations are
frequently used to measure the burden of this chronic
disease (45,46). Fourth, increases in prevalence of comor-
bidities may be due to ascertainment or detection bias. For
instance, we observed a dramatic increase in the rate of
comorbid kidney disease in our study, a finding which may
have been influenced by increased detection of mild renal
dysfunction as a result of the adoption of glomerular
filtration rate estimation with routine laboratory results (47).
ifth, temporal changes in coding practice may have in-
reased the prevalence of heart failure as a secondary
iagnosis due to financial incentives related to “upcoding” of
omplicating conditions (48). As a result, we were unable to
erify the reason for observed trends in heart failure hospi-
alizations; we believe this is an area for further research.
onclusions
espite trends showing a decrease in primary heart failure
ospitalizations, this chronic disease still accounts for over 1
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patients with heart failure experience over 3 million second-
ary hospitalizations annually, often due to related comorbid
conditions. In total, heart failure is associated with over 4
million hospitalizations per year in the United States and
imparts a substantial burden on both patients and the
healthcare system. Recent interventions do not appear to
have decreased the significant number of heart failure–
related hospitalizations during the past decade. Future
strategies to reduce hospitalizations of heart failure patients
should consider both cardiac disease and noncardiac comor-
bid conditions.
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